Precision Events - Society for Immunotherapy of Cancer (SITC) 2026

Precision for Medicine is excited to attend the SITC 2026 Annual Meeting at the Phoenix Convention Center rom November 4-8, 2026. Each year SITC brings together leading researchers, clinicians, innovators advancing the science and application of cancer immunotherapy.

For Precision for Medicine, immunotherapy innovation represents one of the most important opportunities to improve patient outcomes. As programs become increasingly complex, success depends on integrated biomarker, translational, and clinical development strategies that can guide decision-making from early research through commercialization.

Whether you're optimizing a biomarker strategy, advancing a novel immunotherapy, or planning your next clinical milestone, connect with our team at SITC to explore how we can help move your program forward with confidence.

Drop by our booth or complete the form below to schedule dedicated time with our team in Phoenix.

Precision Experts at SITC 2026

Paz Vellanki, MD, PhD

Vice President, Clinical Development, Oncology

(SizeLimitingPyList: [linkedin])
Angelina Bisconte

Vice President, Translational Biology

(SizeLimitingPyList: [linkedin])
Danielle Ashley

Senior Vice President, Strategic Business Development, Translational Services

(SizeLimitingPyList: [linkedin])
Tania Wiens

Regional Vice President, Business Development

(SizeLimitingPyList: [linkedin])

Related Resources

Whether you're advancing a novel therapy or scaling a global program, we're here to help you move forward with clarity and confidence.

Explore Resources

Brochure
Translational and Biomarker Sciences: Enabling Breakthroughs
Download Brochure
Brochure
Every Decision Starts With the Right Biospecimen
Download Brochure
Webinar
AI & Multi-Omics for Translational Research
Watch Webinar
Case Study
Using Epigenetic Immune Cell Profiling to Provide Insight into the Tumor Microenvironment in B-Cell Non-Hodgkin Lymphoma
Download Case Study